Бегущая строка

SRCL $43.20 -0.4494%
EUSC $34.30 0.2104%
8535.HK $0.14 0.7463%
2313.HK $67.40 -1.462%
0VQA.L $22.08 -4.053%
HZO $27.37 -2.25%
0L8F.L $28.44 -1.8072%
CLVS $0.08 -24.1122%
BRAC $10.64 0%
0766.HK $0.04 0%
0HVA.L $3.43 1.1799%
GLE.PA $22.06 1.1927%
CMOU.SI $0.32 -1.5385%
PWUP $10.53 0%
PGAL $10.80 0.089%
STEP $21.52 -0.6005%
GREE $0.38 -5.6089%
MSCI $463.96 -1.369%
STRN $1.34 -16.25%
SCHD $69.67 -0.3432%
EJF0.L $119.00 2.1459%
TRCA $10.41 0.5797%
EPAB.PA $26.01 0.814%
FTLB $20.90 8.07014%
HLCL.L $275.50 -5%
PSG.MC $1.69 0%
AMGN $232.25 -0.0172%
FSRXU $10.37 0%
FGLS.L $5.66 0.6495%
KONG $24.26 0.0619%
PPC.L $155.00 0%
8042.HK $0.09 0%
MVRL $16.44 -0.937%
3816.HK $0.22 3.3654%
0285.HK $23.90 -1.6461%
IDN $2.26 1.8018%
NWLG $19.61 0%
PRPL $3.02 1.1745%
0122.HK $0.17 0%
EVGRU $11.00 0%
BAIN.PA $99.20 1.4315%
0813.HK $4.42 0%
1281.HK $0.06 -4.6154%
GSL-PB $25.11 0.0331%
GDP $23.02 0%
CEG.L $0.10 0%
IPVIW $0.00 0%
WVFC $12.40 0%
0769.HK $0.46 -2.1505%
LPTX $0.43 0.7765%
RISE $19.95 0%
NUSI $19.90 -0.2627%
CLR $74.27 0%
UPC $0.66 -4.3333%
0362.HK $0.25 4.6413%
SRNG $11.42 0%
ZS $113.97 -1.2563%
AGX $41.19 -0.097%
AV.L $412.70 -0.4102%
STJ.L $1 138.00 -0.6114%
SUZB3.SA $42.56 2.3815%
FLXN $9.12 0%
OP $0.24 0%
STBX $3.44 -1.7143%
DZZ $2.32 0.4329%
HBANN $25.09 0%
VRSN $220.53 0.0272%
QULL $23.99 0%
0699.HK $3.98 0%
0778.HK $6.23 -1.735%
IGR.L $161.50 1.5723%
RENW.L $11.76 2.2969%
8176.HK $0.30 11.3208%
2162.HK $61.20 0%
DNN $1.09 -1.7387%
PSC $38.70 -0.5394%
JHMD $31.20 -0.2558%
CASA $1.10 -3.0973%
GOSS $1.25 -7.7778%
IGEA.L $87.50 -0.506%
MOV $25.35 -0.1182%
ESLT $190.62 -1.5011%
UGDV.L $15.65 0%
VELO $10.02 0%
MKTW $1.81 0.838%
IWFH $13.84 0%
XMHQ $72.85 -0.4101%
ZEST $0.17 0%
AZZ $35.51 -1.5252%
PEB-PH $17.26 0.116%
0272.HK $1.00 0%
3390.HK $4.80 3.8961%
OPTT $0.50 -0.2196%
FORD $1.02 0%
CSRN3.SA $23.00 0%
FNDE $26.30 -1.0906%
XGSG.L $2 414.75 -0.2685%
0251.HK $2.16 0%
LAB $1.77 -0.5618%
ENFAW $0.98 0%

Хлебные крошки

Акции внутренные

Лого

Pulse Biosciences, Inc. PLSE

$8.26

+$0.71 (8.54%)
На 18:01, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    312288810.00000000

  • week52high

    9.69

  • week52low

    1.18

  • Revenue

    700000

  • P/E TTM

    -4

  • Beta

    1.11003400

  • EPS

    -2.27000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    11 мая 2023 г. в 20:00

Описание компании

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Рекомендации
аналитиков

Рекомендации аналитиков — понятие, что это такое и как.

Рекомендации аналитиков

Grading company New grade Previous grade Recommendation date
HC Wainwright & Co. Neutral Buy 13 мая 2022 г.
Stephens & Co. Overweight Overweight 01 апр 2022 г.
HC Wainwright & Co. Buy Buy 01 апр 2022 г.
HC Wainwright & Co. Buy Buy 10 февр 2022 г.
HC Wainwright & Co. Buy Buy 16 ноя 2021 г.
Maxim Group Hold Buy 21 сент 2022 г.

Свежие комментарии

Свежие комментарии

Оставьте свой голос

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%
  • Нет

    12%

Проголосовал 8 человек

Новостная лента
компании

Новостная лента

  • Изображение

    Pulse Biosciences, Inc. (PLSE) Q1 2023 Earnings Call Transcript

    Seeking Alpha

    11 мая 2023 г. в 21:59

    Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Trip Taylor - Investor Relations Kevin Danahy - President & Chief Executive Officer Darrin Uecker - Chief Technology Officer Mike Koffler - Vice President of Finance Robert Duggan – Executive Chairman Conference Call Participants Robert Lovgren – Medical Hope Productions Operator Good afternoon, ladies and gentlemen and thank you for standing by. Welcome to the Pulse Biosciences First Quarter 2023 Earnings Conference Call.

  • Изображение

    Pulse Biosciences Inc. (PLSE) Q4 2022 Earnings Call Transcript

    Seeking Alpha

    30 мар 2023 г. в 20:41

    Pulse Biosciences Inc. (NASDAQ:PLSE ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Trip Taylor – Investor Relations Kevin Danahy – President and Chief Executive Officer Darrin Uecker – Chief Technology Officer Robert Duggan – Executive Chairman Conference Call Participants Robert Lovgren – Medical Hope Productions James Hollingsworth – Private Investor Operator Ladies and gentlemen, greetings, and welcome to the Pulse Biosciences' Fourth Quarter 2022 Earnings Conference Call. At this time all participants lines are in a listen-only mode.

  • Изображение

    Pulse Biosciences, Inc. (PLSE) Q3 2022 Earnings Call Transcript

    Seeking Alpha

    10 ноя 2022 г. в 20:02

    Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Philip Taylor – Investor Relations, Gilmartin Group Kevin Danahy – President and Chief Executive Officer Darrin Uecker – Chief Technology Officer Sandy Gardiner – Executive Vice President and Chief Financial Officer Conference Call Participants Operator Greetings and welcome to Pulse Biosciences Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

  • Изображение

    Hot Penny Stocks To Watch As The Stock Market Crash Continues

    PennyStocks

    26 сент 2022 г. в 14:30

    Hot penny stocks to add to your watch list this week. Is it time to buy?

  • Изображение

    Pulse Biosciences, Inc. (PLSE) CEO Darrin Uecker on Q2 2022 Results - Earnings Call Transcript

    Seeking Alpha

    10 авг 2022 г. в 19:40

    Pulse Biosciences, Inc. (NASDAQ:PLSE ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group Darrin Uecker - President and Chief Executive Officer Kevin Danahy - Chief Commercial Officer Sandra Gardiner - Executive Vice President and Chief Financial Officer Conference Call Participants Jeremy Pearlman - Maxim Group LLC Swayampakula Ramakanth - H.C. Wainwright & Co, LLC Operator Greetings, and welcome to Pulse Biosciences Second Quarter 2022 Earnings Conference Call.



Insider Summary

Insider Summary

Reporting Name Acquistion/Disposition Owned Transacted Transaction Date
Levinson Mitchell E. A 5034 4300 07 окт 2022 г.
Levinson Mitchell E. A 5234 4500 07 окт 2022 г.
Levinson Mitchell E. A 5134 4400 07 окт 2022 г.
Levinson Mitchell E. A 12945 8810 07 окт 2022 г.
Levinson Mitchell E. A 46274 8770 07 окт 2022 г.
Danahy Kevin Patrick A 6500 6500 30 сент 2022 г.
Danahy Kevin Patrick A 450000 450000 23 сент 2022 г.
DUGGAN ROBERT W A 81025 81025 09 июн 2022 г.
DUGGAN ROBERT W A 5683163 5683163 09 июн 2022 г.
DUGGAN ROBERT W A 411044 81025 09 июн 2022 г.